141 related articles for article (PubMed ID: 11056287)
1. An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria.
Kubo S; Orihara Y; Kitamura O; Ikematsu K; Tsuda R; Nakasono I
Forensic Sci Int; 2001 Jan; 115(1-2):155-8. PubMed ID: 11056287
[TBL] [Abstract][Full Text] [Related]
2. Enzyme elevations in the neuroleptic malignant syndrome.
Gurrera RJ; Romero JA
Biol Psychiatry; 1993 Nov; 34(9):634-40. PubMed ID: 8292692
[TBL] [Abstract][Full Text] [Related]
3. Fatal neurotoxic response to neuroleptic medications: case report and review of the literature.
Sheil AT; Collins KA; Schandl CA; Harley RA
Am J Forensic Med Pathol; 2007 Jun; 28(2):116-20. PubMed ID: 17525560
[TBL] [Abstract][Full Text] [Related]
4. All elevated creatine kinase is not neuroleptic malignant syndrome.
Maniam T; Rahman MA
Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
[TBL] [Abstract][Full Text] [Related]
5. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
[TBL] [Abstract][Full Text] [Related]
7. High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome.
Hermesh H; Manor I; Shiloh R; Aizenberg D; Benjamini Y; Munitz H; Weizman A
J Clin Psychopharmacol; 2002 Jun; 22(3):252-6. PubMed ID: 12006894
[TBL] [Abstract][Full Text] [Related]
8. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
Erol A; Putgül G; Sert E; Mete L
Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation.
Ayanoğlu M; Korgali E; Sezer T; Aydin HI; Sönmez FM
Brain Dev; 2020 May; 42(5):418-420. PubMed ID: 32173091
[TBL] [Abstract][Full Text] [Related]
11. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
13. CPK in NMS.
Craddock B; Craddock N; Milner G
Br J Psychiatry; 1991 Jan; 158():130. PubMed ID: 2015437
[No Abstract] [Full Text] [Related]
14. The role of creatine kinase in the diagnosis of neuroleptic malignant syndrome.
O'Dwyer AM; Sheppard NP
Psychol Med; 1993 May; 23(2):323-6. PubMed ID: 8101383
[TBL] [Abstract][Full Text] [Related]
15. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ; Wilborn CA
Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
[TBL] [Abstract][Full Text] [Related]
16. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature.
Masi G; Milone A; Viglione V; Mancini A; Pisano S
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):536-42. PubMed ID: 25387323
[TBL] [Abstract][Full Text] [Related]
17. [The malignant neuroleptic syndrome and malignant hyperthermia].
Mitterschiffthaler G; Hackl JM; Neumann R
Anaesthesist; 1989 Apr; 38(4):210-3. PubMed ID: 2729540
[TBL] [Abstract][Full Text] [Related]
18. Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level.
Tanii H; Taniguchi N; Niigawa H; Hosono T; Ikura Y; Sakamoto S; Kudo T; Nishimura T; Takeda M
Brain Res; 1996 Dec; 743(1-2):263-70. PubMed ID: 9017254
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
20. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
